JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type I… Read more
Market Cap & Net Worth: JCR Pharmaceuticals Co., Ltd. (JCR)
JCR Pharmaceuticals Co., Ltd. (F:JCR) has a market capitalization of $403.19 Million (€392.79 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #14110 globally and #1471 in its home market, demonstrating a -3.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JCR Pharmaceuticals Co., Ltd.'s stock price €3.22 by its total outstanding shares 121983806 (121.98 Million).
JCR Pharmaceuticals Co., Ltd. Market Cap History: 2026 to 2026
JCR Pharmaceuticals Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $403.19 Million to $403.19 Million (0.00% CAGR).
JCR Pharmaceuticals Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JCR Pharmaceuticals Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of JCR by Market Capitalization
Companies near JCR Pharmaceuticals Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to JCR Pharmaceuticals Co., Ltd. by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
JCR Pharmaceuticals Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, JCR Pharmaceuticals Co., Ltd.'s market cap moved from $403.19 Million to $ 403.19 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €403.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of JCR Pharmaceuticals Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $403.19 Million USD |
| MoneyControl | $403.19 Million USD |
| MarketWatch | $403.19 Million USD |
| marketcap.company | $403.19 Million USD |
| Reuters | $403.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.